Technical Analysis for TRIB - Trinity Biotech plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
20 DMA Support | Bullish | -3.98% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -3.98% | |
Wide Bands | Range Expansion | -3.98% | |
Down 3 Days in a Row | Weakness | -3.98% |
Alert | Time |
---|---|
20 DMA Resistance | about 22 hours ago |
Possible NR7 | about 22 hours ago |
60 Minute Opening Range Breakdown | 1 day ago |
Down 5% | 1 day ago |
Down 3% | 1 day ago |
Get this analysis on your stocks daily!
- Earnings date: 09/27/2024
Trinity Biotech plc Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. It offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as bacterial and viral diseases, and autoimmune disorders; products for the in-vitro diagnostic testing for haemoglobin A1c (HbA1c) used in the monitoring and diagnosis of diabetes; Hb variants for the detection of Hemoglobinapothies; and reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for detecting liver and kidney diseases, and haemolytic anaemia. The company also provides UniGold HIV, a POC diagnostic test, which is carried out in the presence of the patient to diagnose the presence of HIV antibodies in the patient. In addition, it sells raw materials to the life sciences industry and research institutes. Its customers include hospitals, clinical and reference laboratories, public health facilities, and other outreach facilities. The company sells its products through its direct sales force in the United States; and a network of independent distributors and strategic partners internationally. Trinity Biotech plc was founded in 1992 and is headquartered in Bray, Ireland.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Acid Infectious Diseases Diabetes Antibodies Phosphates Kidney Disease Hydrogen Glucose Medical Test Diagnostic Products Blood Test Diagnostic Tests HIV Public Health Autoimmune Disorders Immune Disorders Hemoglobin Viral Disease Laboratory Products Medical Diagnostic Medical Diagnosis Bile Acid Medical Diagnostic Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.55 |
52 Week Low | 1.0509 |
Average Volume | 1,729,490 |
200-Day Moving Average | 2.10 |
50-Day Moving Average | 1.65 |
20-Day Moving Average | 1.76 |
10-Day Moving Average | 1.80 |
Average True Range | 0.19 |
RSI (14) | 48.98 |
ADX | 22.02 |
+DI | 28.39 |
-DI | 23.64 |
Chandelier Exit (Long, 3 ATRs) | 1.63 |
Chandelier Exit (Short, 3 ATRs) | 1.70 |
Upper Bollinger Bands | 2.13 |
Lower Bollinger Band | 1.39 |
Percent B (%b) | 0.41 |
BandWidth | 42.31 |
MACD Line | 0.07 |
MACD Signal Line | 0.06 |
MACD Histogram | 0.0103 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.83 | ||||
Resistance 3 (R3) | 1.83 | 1.80 | 1.80 | ||
Resistance 2 (R2) | 1.80 | 1.76 | 1.79 | 1.79 | |
Resistance 1 (R1) | 1.74 | 1.74 | 1.73 | 1.74 | 1.79 |
Pivot Point | 1.71 | 1.71 | 1.70 | 1.70 | 1.71 |
Support 1 (S1) | 1.65 | 1.67 | 1.64 | 1.65 | 1.59 |
Support 2 (S2) | 1.62 | 1.65 | 1.61 | 1.59 | |
Support 3 (S3) | 1.56 | 1.62 | 1.58 | ||
Support 4 (S4) | 1.56 |